Clinical Trial Update: Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH [Phase 2]

View source ↗

Summary

Phase 2a trial evaluating the safety and preliminary efficacy of J2H-1702 in non-alcoholic steatohepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• J2H-1702 (J2H-1702)

Snippet

Sponsor: J2H Biotech | Conditions: Non-alcoholic Steatohepatitis | Phase 2 | Status: COMPLETED